Mingyue Optical Lens Co.,Ltd. Share Price

Equities

301101

CNE1000054R1

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
26.95 CNY +1.81% Intraday chart for Mingyue Optical Lens Co.,Ltd. +4.50% -35.62%

Financials

Sales 2024 * 903M 125M 9.95B Sales 2025 * 1.1B 152M 12.11B Capitalization 5.41B 747M 59.62B
Net income 2024 * 198M 27.34M 2.18B Net income 2025 * 246M 33.97M 2.71B EV / Sales 2024 * 5.99 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 4.92 x
P/E ratio 2024 *
27.4 x
P/E ratio 2025 *
22.1 x
Employees 962
Yield 2024 *
1.41%
Yield 2025 *
1.51%
Free-Float 26.89%
More Fundamentals * Assessed data
Dynamic Chart
Mingyue Optical Lens Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Huhu Health Technology Co., Ltd. announced that it expects to receive CLP 12 million in funding from Mingyue Optical Lens Co.,Ltd., Shanghai Mingyue Industrial Co., Ltd. and another investor. CI
Tranche Update on Mingyue Optical Lens Co.,Ltd.'s Equity Buyback Plan announced on October 26, 2023. CI
Mingyue Optical Lens Co.,Ltd.'s Equity Buyback announced on October 25, 2023, has closed with 779,482 shares, representing 0.39% for CNY 30 million. CI
Mingyue Optical Lens Co.,Ltd. announces an Equity Buyback for CNY 30 million worth of its shares. CI
Mingyue Optical Lens Co.,Ltd. authorizes a Buyback Plan. CI
Mingyue Optical Lens Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Mingyue Optical Lens Co.,Ltd.(XSEC:301101) added to S&P Global BMI Index CI
Mingyue Optical Lens Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Mingyue Optical Lens Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Mingyue Optical Lens Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Mingyue Optical Lens Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Mingyue Optical Lens Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
VR Products Maker Wahlap Technology to Free Up 10% Stake For Trading MT
Mingyue Optical Lens to Free Up 1.2% Restricted Stake For Trading MT
More news
1 day+1.81%
1 week+4.50%
Current month-3.99%
1 month-2.53%
3 months-16.85%
6 months-25.66%
Current year-35.62%
More quotes
1 week
25.22
Extreme 25.22
27.45
1 month
24.21
Extreme 24.21
28.92
Current year
23.12
Extreme 23.12
41.86
1 year
23.12
Extreme 23.12
49.27
3 years
18.81
Extreme 18.8067
52.03
5 years
18.81
Extreme 18.8067
52.03
10 years
18.81
Extreme 18.8067
52.03
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 14/11/19
Chairman 41 31/12/14
Director/Board Member 43 31/12/14
Members of the board TitleAgeSince
Director/Board Member 69 14/11/19
Director/Board Member 44 14/11/19
Chairman 57 14/11/19
More insiders
Date Price Change Volume
26/04/24 26.95 +1.81% 1,521,446
25/04/24 26.47 +0.88% 1,182,188
24/04/24 26.24 +1.98% 1,238,700
23/04/24 25.73 -5.75% 2,508,876
22/04/24 27.3 +5.85% 1,914,796

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes
Mingyue Optical Lens Co Ltd is a China-based company primarily engaged in the research, development, design, production and sales of eye optic products such as spectacle lenses, lens resin materials, finished lenses, and frames. Lens products include myopia lenses, plan lenses and hyperopia lenses based on different diopters. Resin lenses are mainly made of polymer resin materials. Finished products are mainly frame glasses, which are composed of frames and lenses. It provides its customers with products under the brand Mingyue Lens. The Company conducts its businesses in the domestic market.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
26.95 CNY
Average target price
40.2 CNY
Spread / Average Target
+49.17%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301101 Stock